09:41 AM EST - Aeterna Zentaris Inc. : Today announced that European Patent Office has issued a patent providing intellectual property protection of macimorelin in 27 countries within the European Union as well as additional European non-EU countries, such as the UK and Turkey, for macimorelin (Ghryvelin®; Macrilen™) for use to diagnose growth hormone deficiency (GHD) in adults. Aeterna Zentaris Inc
shares T.AEZS are trading unchanged at $0.41.
